Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)

Ken-ichi Aiha ,  a ,  Masataka Sata

Diabetes and Metabolism Journal

2015 .01

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

서성환 ,  서기현 ,  정창희 외 5명

Diabetes and Metabolism Journal

2015 .01

Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)

Antoni Sic ,  as-Maina ,  Ruth Nava 외 2명

Diabetes and Metabolism Journal

2015 .01

Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)

석한나

Diabetes and Metabolism Journal

2015 .01

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors

홍상모 ,  정창희 ,  한송 외 1명

Diabetes and Metabolism Journal

2022 .01

Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies

Dimit ,  ios Patoulias ,  Michael Doumas

Endocrinology and Metabolism

2021 .08

Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World- Based Cohort Study (Diabetes Metab J 2019;43:640-8)

문준성

Diabetes and Metabolism Journal

2019 .01

New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors

정찬희

Endocrinology and Metabolism

2021 .01

Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601)

김다래

Diabetes and Metabolism Journal

2020 .01

Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90-6)

구보경

Diabetes and Metabolism Journal

2019 .01

Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90-6)

백인경

Diabetes and Metabolism Journal

2019 .01

Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects

Muhammad Shahid ,  Minhyung Kim ,  Austin Yeon 외 4명

International Neurourology Journal

2020 .01

Letter: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65)

김성우

Diabetes and Metabolism Journal

2020 .01

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)

Gunt ,  am Sche ,  nthane

Diabetes and Metabolism Journal

2021 .01

Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93)

김남훈

Diabetes and Metabolism Journal

2017 .01

Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93)

윤재승 ,  고승현

Diabetes and Metabolism Journal

2017 .01

Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease

최훈지 ,  고예희 ,  문선준 외 11명

Endocrinology and Metabolism

2024 .08